Bellevue Group’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-68,665
Closed -$2.42M 193
2025
Q4
$2.42M Sell
68,665
-7,417
-10% -$263K 0.05% 92
2025
Q3
$2M Buy
+76,082
New +$2.27M 0.04% 97
2025
Q1
Sell
-12,939
Closed -$521K 168
2024
Q4
$521K Sell
12,939
-3,240
-20% -$185K 0.01% 125
2024
Q3
$1.02M Buy
16,179
+11,779
+268% +$691K 0.02% 118
2024
Q2
$233K Sell
4,400
-1,000
-19% -$65.6K ﹤0.01% 144
2024
Q1
$443K Sell
5,400
-12,100
-69% -$538K 0.01% 134
2023
Q4
$326K Buy
+17,500
New +$229K 0.01% 146
2023
Q3
Sell
-33,000
Closed -$535K 164
2023
Q2
$535K Buy
+33,000
New +$691K 0.01% 142
2019
Q3
Sell
-96,000
Closed -$797K 221
2019
Q2
$797K Buy
+96,000
New +$820K 0.01% 143

Other funds holding VKTX